Coronavirus: On Request For Sputnik 5 Vaccine Approval, Subject Expert Committee Seeks More Data From Dr Reddy's Laboratories: Sources
The Sputnik vaccine has an efficacy of 91.6 per cent. New Delhi: The Subject Expert Committee (SEC) of the Indian drug regulator has asked pharma giant Dr Reddy's Laboratories, the Indian manufacturer of Sputnik V, the Russia-developed coronavirus vaccine, for more data regarding its application for emergency use approval for the vaccine, sources said. Dr Reddy's Laboratories had approached the Drug Controller General of India (DGCI) on February 19 to get approval for the emergency use of Sputnik V. The vaccine has an efficacy of 91.6 per cent. On Wednesday, the company presented the safety ...
Source: ndtv.com